- Home
- SPHL vs SILO Comparison
SPHL vs SILO Comparison
Compare SPHL & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPHL
- SILO
- Stock Information
- Founded
- SPHL 2002
- SILO 2010
- Country
- SPHL Singapore
- SILO United States
- Employees
- SPHL N/A
- SILO N/A
- Industry
- SPHL Homebuilding
- SILO Apparel
- Sector
- SPHL Consumer Discretionary
- SILO Consumer Discretionary
- Exchange
- SPHL Nasdaq
- SILO Nasdaq
- Market Cap
- SPHL 10.0M
- SILO 8.0M
- IPO Year
- SPHL 2024
- SILO N/A
- Fundamental
- Price
- SPHL $0.44
- SILO $0.41
- Analyst Decision
- SPHL
- SILO
- Analyst Count
- SPHL 0
- SILO 0
- Target Price
- SPHL N/A
- SILO N/A
- AVG Volume (30 Days)
- SPHL 982.1K
- SILO 371.9K
- Earning Date
- SPHL 12-29-2025
- SILO 11-13-2025
- Dividend Yield
- SPHL N/A
- SILO N/A
- EPS Growth
- SPHL N/A
- SILO N/A
- EPS
- SPHL N/A
- SILO N/A
- Revenue
- SPHL $5,956,226.00
- SILO $72,102.00
- Revenue This Year
- SPHL N/A
- SILO $1.86
- Revenue Next Year
- SPHL N/A
- SILO N/A
- P/E Ratio
- SPHL N/A
- SILO N/A
- Revenue Growth
- SPHL N/A
- SILO N/A
- 52 Week Low
- SPHL $0.35
- SILO $0.40
- 52 Week High
- SPHL $7.80
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- SPHL 41.03
- SILO 26.04
- Support Level
- SPHL $0.40
- SILO $0.44
- Resistance Level
- SPHL $0.47
- SILO $0.48
- Average True Range (ATR)
- SPHL 0.12
- SILO 0.04
- MACD
- SPHL -0.02
- SILO -0.01
- Stochastic Oscillator
- SPHL 9.71
- SILO 0.00
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.